Basic Information
Juniper Genomics is a health technology company that sets new standards in IVF care. It is revolutionizing IVF care through the world's first embryo screening test using whole-genome and transcriptome sequencing. Founded by leading experts in genomics, reproductive medicine, and bioethics, Juniper provides the most comprehensive and clinically actionable insights, helping patients and doctors make more informed decisions during IVF. Unlike traditional tests, Juniper’s approach analyzes millions of genetic markers to identify conditions associated with IVF failure, miscarriage, and postnatal health without relying on controversial polygenic risk scores. By combining cutting-edge science with a robust ethical framework, Juniper Genomics is shaping the future of reproductive technology and setting a new benchmark for embryo health assessment.
Embryome Inc.
Toronto,Ontario,Canada
less than 15 people
January 01, 2020
--

